Variable | Non adjusted hazard ratio | 95% Confident interval | P value | Adjusted hazard ratio | 95% Confident interval | P value |
---|---|---|---|---|---|---|
Age (1-year increment) | 1.053 | 1.041ā1.066 | <0.0001 | 1.030 | 1.016ā1.044 | <0.0001 |
Male gender | 1.01 | 0.69ā1.46 | 0.96 | Ā | Ā | Ā |
SAPS II score (1-point increment) | 1.037 | 1.035ā1.049 | <0.0001 | 1.023 | 1.010ā1.036 | <0.01 |
Mental disorder | ||||||
Ā Anxiety disorder | 0.47 | 0.21ā1.07 | 0.07 | Ā | Ā | Ā |
Ā Schizophrenia | 1.67 | 0.87ā3.20 | 0.12 | Ā | Ā | Ā |
Ā Psychotic disorder other than schizophrenia | 1.57 | 0.98ā2.52 | 0.06 | Ā | Ā | Ā |
Ā Depression disorder | 0.80 | 0.55ā1.16 | 0.24 | Ā | Ā | Ā |
Ā Bipolar disorder | 1.18 | 0.65ā2.14 | 0.59 | Ā | Ā | Ā |
Substance dependence (alcohol or drug addiction) | 1.12 | 0.79ā1.16 | 0.42 | Ā | Ā | Ā |
Transfer from psychiatric hospital or ward | 1.79 | 1.01ā3.19 | 0.04 | Ā | Ā | Ā |
Psychoactive medication before admission | ||||||
Ā None | 1.17 | 0.72ā2.05 | 0.58 | Ā | Ā | Ā |
Ā Benzodiazepines | 0.97 | 0.80ā1.90 | 0.80 | Ā | Ā | Ā |
Ā Neuroleptics | 1.16 | 0.78ā1.72 | 0.47 | Ā | Ā | Ā |
Ā Antipsychotics other than neuroleptics | 1.08 | 0.80ā1.47 | 0.60 | Ā | Ā | Ā |
Ā Lithium | 1.59 | 0.77ā3.26 | 0.21 | Ā | Ā | Ā |
Ā SSRIs | 0.84 | 0.53ā1.32 | 0.44 | Ā | Ā | Ā |
Ā SNRIs | 0.34 | 0.11ā1.05 | 0.48 | Ā | Ā | Ā |
Ā Tri- or tetracyclics antidepressants | 0.52 | 0.21ā1.27 | 0.52 | Ā | Ā | Ā |
Ā MAOIs | 0.89 | 0.63ā1.24 | 0.42 | Ā | Ā | Ā |
Reason for admission | ||||||
Ā Deliberate self-poisoning with psychoactive medications alone | 0.30 | 0.20ā0.44 | <0.0001 | Ā | Ā | Ā |
Ā Deliberate self-poisoning with psychoactive medications and/or non-psychoactive medications | 0.11 | 0.10ā0.78 | 0.03 | Ā | Ā | Ā |
Ā Deliberate self-poisoning with psychoactive medications and/or with pesticides, household or industrial products | 0.45 | 0.17ā1.19 | 0.11 | Ā | Ā | Ā |
Ā Deliberate self-poisoning with psychoactive medications and/or with hanging, drowning, jumping from buildings or corrosive chemicals ingestion | 1.06 | 0.12ā2.84 | 0.86 | Ā | Ā | Ā |
Ā Respiratory failure | 3.28 | 2.11ā3.99 | <0.0001 | 2.33 | 1.19ā4.57 | 0.01 |
Ā Shock | 6.30 | 3.76ā5.92 | <0.0001 | 3.72 | 1.97ā6.62 | <0.001 |
Ā CNS or peripheral disorder | 2.18 | 1.14ā4.17 | 0.02 | Ā | Ā | Ā |
Ā Metabolic disorder | 1.50 | 0.61ā3.67 | <0.38 | Ā | Ā | Ā |
Ā Out-of-hospital cardiac arrest | 4.52 | 0.63ā7.79 | 0.13 | Ā | Ā | Ā |
Ā Acute kidney injury | 4.35 | 1.27ā6.24 | 0.01 | Ā | Ā | Ā |
Ā Non-deliberate psychoactive medication overdose | 1.34 | 0.56ā3.71 | 0.54 | Ā | Ā | Ā |
Ā Miscellaneous | 1.50 | 0.48ā4.43 | 0.48 | Ā | Ā | Ā |
Chemical pneumonitis and/or aspiration pneumonia [n (%)] | 1.18 | 0.67ā1.57 | 0.99 | Ā | Ā | Ā |
Organ support in the ICU | ||||||
Ā Invasive mechanical ventilation | 0.84 | 0.57ā1.24 | 0.38 | Ā | Ā | Ā |
Ā Vasopressors | 2.01 | 1.39ā3.10 | <0.0001 | Ā | Ā | Ā |
Ā Renal replacement therapy | 1.89 | 1.11ā2.21 | 0.02 | Ā | Ā | Ā |
ICU outcomes | ||||||
Ā Acquired infection at any site | 2.62 | 1.87ā5.37 | <0.01 | Ā | Ā | Ā |